Item 7.01 Regulation FD Disclosure
On September 9, 2021, Omnicell, Inc. (the "Company") issued a press release
announcing the closing of the Company's acquisition of RxInnovation Inc., a
Delaware corporation, operating as FDS Amplicare. A copy of the press release is
attached hereto as Exhibit 99.1 and is hereby furnished pursuant to this Item
7.01.

The information in this Item 7.01 and Exhibit 99.1 is furnished and shall not be
deemed "filed" for purposes of Section 18 of the Securities Exchange Act of
1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities
of that section, and shall not be incorporated by reference into any Company
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit Number                                          Description of

Document


      99.1                Press release entitled "Omnicell Completes

Acquisition of FDS Amplicare" dated

September 9, 2021

       104              Cover Page Interactive Data File (embedded within the inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses